Stent Grafts Market Size, Share, Growth, and Industry Analysis, By Type (Abdominal Aortic Stent Grafts,Thoracic Aortic Stent Grafts,Fenestrated Aortic Stent Grafts), By Application (Hospitals,Ambulatory Surgical Centers,Others), Regional Insights and Forecast to 2035

Stent Grafts Market Overview

The global Stent Grafts Market size is projected to grow from USD 5980.59 million in 2026 to USD 6433.92 million in 2027, reaching USD 11546.13 million by 2035, expanding at a CAGR of 7.58% during the forecast period.

The global stent grafts market is a critical segment of the vascular surgery and endovascular treatment space, projected to treat over 2 million patients worldwide annually by 2025. The market is driven by the increasing incidence of abdominal aortic aneurysms (AAA), thoracic aortic aneurysms (TAA), and other vascular diseases, with over 200,000 endovascular procedures performed annually across major markets. Approximately 60% of these procedures involve abdominal aortic stent grafts, while thoracic aortic stent grafts account for around 30%, reflecting their growing clinical acceptance.

In the USA, the stent grafts market serves more than 350,000 patients yearly, representing nearly 40% of the global volume. Abdominal aortic aneurysm repair procedures exceed 130,000 annually, with stent graft adoption reaching 85% in these surgeries. The USA leads with over 1,200 hospitals equipped for advanced endovascular stent graft deployment.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Over 68% of vascular surgeons prefer endovascular stent grafts over open surgery for aneurysm repair due to lower complication rates.
• Major Market Restraint: Nearly 42% of patients experience complications related to stent graft migration or endoleaks, limiting wider acceptance.
• Emerging Trends: Around 30% of new product developments focus on fenestrated and branched stent graft designs to target complex anatomies.
• Regional Leadership: North America holds a dominant 38% market share, followed by Europe at 31%, driven by advanced healthcare infrastructure.
• Competitive Landscape: Top 5 companies control nearly 70% of the global stent grafts market, with aggressive patent filings and mergers.
• Market Segmentation: Abdominal aortic stent grafts account for 60% market share, thoracic stent grafts 30%, and fenestrated grafts the remaining 10%.
• Recent Development: Approximately 25% of recent product launches involve drug-eluting stent grafts to reduce restenosis risk.

Stent Grafts Market Latest Trends

The latest trends in the stent grafts market include a significant shift towards minimally invasive procedures, with more than 75% of aneurysm repairs now performed via endovascular techniques rather than open surgery. Innovations in device technology, such as fenestrated and branched grafts, have enabled treatment of anatomically complex cases, representing around 30% of all new product launches globally. Enhanced imaging guidance systems are also being integrated, improving deployment accuracy in over 65% of procedures. The rise in elderly populations globally—projected to exceed 1.5 billion by 2050—fuels demand for safer, less invasive stent grafts.

Stent Grafts Market Dynamics

The stent grafts market dynamics are shaped by multiple interrelated factors influencing growth, challenges, and opportunities globally. The rising prevalence of aortic aneurysms, with an estimated 1-2% of the population affected, drives demand for minimally invasive treatment options, positioning stent grafts as a preferred intervention. Over 350,000 endovascular aneurysm repair (EVAR) procedures are performed annually worldwide, with more than 75% utilizing stent graft technology. Increasing longevity has expanded the elderly population to over 700 million globally, of whom nearly 15% suffer from vascular diseases requiring treatment, thus supporting market expansion.

DRIVER

"Rising Prevalence of Aortic Aneurysms"

The primary driver of stent graft market growth is the rising prevalence of aortic aneurysms, with approximately 1-2% of the global population affected by abdominal aortic aneurysms, translating to over 10 million patients worldwide. The annual number of aneurysm-related deaths exceeds 100,000 globally, underscoring the urgency for effective treatment. In addition, the expanding geriatric demographic—over 700 million individuals aged 65 and above in 2020—further escalates demand for stent graft interventions.

RESTRAINT

"Complications and Device Limitations"

A significant restraint in the stent grafts market stems from procedural complications such as endoleaks, stent migration, and graft occlusion, reported in approximately 20-25% of EVAR cases within the first year post-implantation. Moreover, nearly 15% of patients require reintervention due to device failure or anatomical changes. Limitations in treating complex aneurysms, such as juxtarenal or thoracoabdominal aneurysms, restrict the market share of standard stent grafts to around 70%.

OPPORTUNITY

"Advancements in Fenestrated and Branched Grafts"

Opportunities in the stent grafts market lie in the development of fenestrated and branched stent grafts designed for complex aortic aneurysms, representing a niche yet rapidly growing segment with a potential market share increase from 10% to 25% by 2025. Enhanced customization through 3D imaging and patient-specific graft design improves procedural success in over 85% of complex cases.

CHALLENGE

"Regulatory Hurdles and Cost Concerns"

The stent grafts market faces challenges from stringent regulatory requirements, with device approvals requiring extensive clinical trials involving over 1,000 patients in many cases. The average time for regulatory clearance exceeds 24 months, increasing development costs. Pricing pressures from healthcare payers, especially in government-funded systems, lead to reimbursement challenges, impacting device adoption.

Stent Grafts Market Segmentation

The stent grafts market is segmented by type into abdominal aortic stent grafts, thoracic aortic stent grafts, and fenestrated aortic stent grafts, each catering to distinct vascular conditions. Abdominal aortic stent grafts hold the largest market share at around 60%, used predominantly in AAA repair. Thoracic aortic stent grafts constitute about 30% of the market, addressing thoracic aortic aneurysms and dissections. Fenestrated grafts, designed for complex aneurysms near renal arteries, occupy a smaller but rapidly expanding 10% share. Applications include hospitals, ambulatory surgical centers, and other healthcare facilities, with hospitals accounting for over 70% of stent graft usage due to advanced surgical capabilities.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Abdominal Aortic Stent Grafts: Abdominal aortic stent grafts dominate the market, accounting for approximately 60% of total usage. These devices are used in over 150,000 endovascular abdominal aneurysm repairs annually worldwide. They are preferred due to minimally invasive deployment and reduced patient recovery time. Advances in graft materials, including expanded polytetrafluoroethylene (ePTFE), are employed in over 75% of devices, enhancing durability and biocompatibility.

The abdominal aortic stent grafts segment is anticipated to reach a market size of approximately USD 2,780.5 million in 2025, accounting for 50% share of the global stent grafts market, with steady growth at a CAGR of 7.6% through 2034, driven by increasing prevalence of abdominal aortic aneurysms and advancements in minimally invasive surgical techniques.

Top 5 Major Dominant Countries in the Abdominal Aortic Stent Grafts Segment

• United States: Market size estimated at USD 1,230 million with 44.2% share and CAGR of 7.5%, propelled by widespread adoption of advanced vascular surgery and high awareness of aneurysm treatment options among the population.
• Germany: Market size reaches USD 410 million, holding 14.7% share with a CAGR of 7.4%, supported by growing number of aortic aneurysm procedures and enhanced reimbursement policies for endovascular therapies.
• Japan: Market size approximates USD 320 million, accounting for 11.5% share and CAGR of 7.3%, driven by an aging population and government initiatives promoting early diagnosis and treatment of vascular diseases.
• China: Market size around USD 270 million, representing 9.7% share with CAGR of 7.8%, backed by rapid expansion of healthcare infrastructure and increased investment in minimally invasive cardiovascular technologies.
• France: Market size near USD 190 million, capturing 6.8% share and CAGR of 7.2%, fueled by increasing surgical interventions and growing focus on preventive cardiovascular healthcare.

Thoracic Aortic Stent Grafts: Thoracic aortic stent grafts represent around 30% of the stent graft market, used in over 80,000 thoracic endovascular aneurysm repair (TEVAR) procedures annually. These grafts are critical in treating thoracic aortic aneurysms and dissections, conditions affecting approximately 15 per 100,000 individuals annually.

The thoracic aortic stent grafts segment is anticipated to reach a market size of approximately USD 1,668 million in 2025, accounting for 30% of the overall stent grafts market, with steady expansion expected at a CAGR of 7.4% through 2034, driven primarily by increasing incidence of thoracic aortic aneurysms and advancements in minimally invasive vascular procedures worldwide.

Top 5 Major Dominant Countries in the Thoracic Aortic Stent Grafts Segment

• United States: Market size estimated at USD 780 million with 46.7% share and CAGR of 7.3%, largely attributable to the high volume of thoracic endovascular aortic repair (TEVAR) procedures and robust healthcare expenditure on cardiovascular devices.
• Germany: Market size reaches USD 210 million, holding 12.6% share with a CAGR of 7.1%, driven by growing awareness around thoracic aortic diseases and the expanding availability of specialized vascular surgery centers.
• Japan: Market size approximates USD 180 million, accounting for 10.8% share and CAGR of 7.2%, boosted by its aging population requiring innovative and less invasive vascular interventions and government initiatives supporting medical device adoption.
• China: Market size near USD 160 million, representing 9.6% share with CAGR of 7.7%, fueled by increasing prevalence of cardiovascular diseases, expanding healthcare infrastructure, and rising access to advanced surgical treatments.
• Italy: Market size close to USD 150 million, capturing 9% share and CAGR of 7.0%, supported by growing investment in cardiovascular healthcare facilities and rising patient preference for minimally invasive procedures.

Fenestrated Aortic Stent Grafts: Fenestrated aortic stent grafts comprise roughly 10% of the market but are growing rapidly. These grafts, customized for patients with juxtarenal and pararenal aneurysms, account for over 20,000 procedures worldwide each year. They offer enhanced precision with fenestrations aligning to renal and visceral arteries, improving patient outcomes.

The fenestrated aortic stent grafts segment is projected to reach a market size of approximately USD 1,111.7 million in 2025, accounting for 20% share of the overall stent grafts market, expanding at a CAGR of 7.5% through 2034, driven by increasing cases of complex aortic aneurysms requiring customized endovascular solutions.

Top 5 Major Dominant Countries in the Fenestrated Aortic Stent Grafts Segment

• United States: Market size estimated at USD 520 million with 46.8% share and CAGR of 7.4%, propelled by high adoption of personalized medical devices and a well-established vascular surgery network.
• Germany: Market size reaches USD 170 million, holding 15.3% share with a CAGR of 7.3%, supported by advancements in imaging technologies facilitating complex graft placements.
• Japan: Market size approximates USD 130 million, accounting for 11.7% share and CAGR of 7.2%, driven by government support for innovative cardiovascular therapies and growing elderly population.
• China: Market size near USD 110 million, representing 9.9% share with CAGR of 7.6%, fueled by rising healthcare expenditure and expanding access to minimally invasive surgical treatments.
• United Kingdom: Market size close to USD 80 million, capturing 7.2% share and CAGR of 7.1%, backed by increasing clinical trials and funding for complex aortic aneurysm repairs.

BY APPLICATION

Hospitals: Hospitals are the primary end-users of stent grafts, accounting for over 70% of total procedures globally. Around 220,000 endovascular aneurysm repairs take place annually in hospital settings, leveraging advanced surgical suites equipped with fluoroscopy and hybrid operating rooms. Hospitals also drive innovation adoption, with over 60% of new stent graft technologies first implemented in tertiary care centers.

The hospitals segment is projected to reach a market size of approximately USD 3,460 million in 2025, capturing around 62% of the global stent grafts market, with a growth rate following a CAGR of 7.6%, as hospitals serve as the primary venues for complex endovascular aneurysm repair procedures due to their advanced infrastructure, imaging suites, and expert surgical teams.

Top 5 Major Dominant Countries in the Hospitals Application Segment

• The United States: Market size estimated at USD 1,830 million, with 52.9% share of the hospitals segment and CAGR of 7.5%, driven by the high volume of EVAR and TEVAR procedures across hospital settings nationwide.
• Germany: Market size reaches USD 520 million, holding 15.0% share with CAGR of 7.4%, supported by robust vascular surgery centers and reimbursement policies favoring hospital-based interventions.
• Japan: Market size approximates USD 400 million, accounting for 11.6% share and CAGR of 7.3%, fueled by an aging population and concentration of advanced vascular surgical capabilities in hospitals.
• China: Market size near USD 350 million, representing 10.1% share with CAGR of 7.8%, backed by increasing hospital upgrades, expansion of cardiovascular care, and improved access to endovascular therapies.
• France: Market size around USD 160 million, capturing 4.6% share with CAGR of 7.2%, driven by hospital-led investments in cardiovascular units and rising demand for aneurysm repair services.

Ambulatory Surgical Centers (ASCs): Ambulatory surgical centers contribute roughly 20% to the stent graft market, benefiting from less invasive procedures enabling same-day discharge. Approximately 60,000 stent graft procedures are performed annually in ASCs, particularly for low-risk patients. Increased investment in ASC infrastructure has grown by 15% annually, promoting market growth in this segment.

The ambulatory surgical centers segment is estimated to reach approximately USD 1,130 million in 2025, contributing about 20% of the stent grafts market share, with projected expansion via a CAGR of 7.5%, as ASCs become more capable of performing lower-risk endovascular graft procedures in outpatient settings with cost efficiencies and shorter hospital stays.

Top 5 Major Dominant Countries in the Ambulatory Surgical Centers Application Segment

• The United States: Market size is estimated at USD 790 million, comprising 69.9% share of the ASC segment and CAGR of 7.6%, propelled by increasing adoption of outpatient procedures and proliferation of specialized ambulatory vascular centers.
• United Kingdom: Market size reaches USD 140 million, holding 12.4% share with CAGR of 7.3%, supported by reforms promoting outpatient care and expansions in ASC infrastructure.
• Germany: Market size approximates USD 120 million, accounting for 10.6% share and CAGR of 7.4%, aided by regulatory incentives for ambulatory surgical models and vascular care decentralization.
• Japan: Market size is near USD 95 million, representing 8.4% share with CAGR of 7.5%, driven by growing acceptance of outpatient vascular interventions and hospital-to-ASC shift in select procedures.
• Canada: Market size stands at USD 60 million, capturing 5.3% share and CAGR of 7.2%, supported by development of outpatient procedure centers and healthcare policy support.

Others: Other applications, including specialized vascular clinics and outpatient centers, represent around 10% of stent graft procedures, primarily supporting follow-up treatments and minor interventions. These centers facilitate patient monitoring post-stent graft implantation, improving long-term care and reducing hospital readmissions by 18%.

The “Others” application segment, encompassing specialty vascular clinics and research institutes, is expected to reach around USD 970 million in 2025, representing roughly 18% of the stent grafts market share, with growth continuing at a CAGR of 7.3%, driven by rising investment in clinical research, pilot trials, and specialized patient treatment centers outside traditional hospital settings.

Top 5 Major Dominant Countries in the Others Application Segment

• The United States: Market size approximated at USD 620 million with 64% share of this segment and CAGR of 7.4%, backed by extensive institutional research centers and specialty vascular clinics.
• Germany: Market size close to USD 140 million, holding 14.4% share with CAGR of 7.3%, driven by strong academic medical centers and innovation hubs conducting vascular graft trials.
• Japan: Market size around USD 80 million, capturing 8.2% share with CAGR of 7.2%, supported by research institutions focusing on advanced graft development and complex case protocols.
• China: Market size near USD 70 million, representing 7.2% share with CAGR of 7.7%, fueled by rising investment in medical research and emerging specialty clinics for vascular care.
• France: Market size of approximately USD 40 million, representing 4.1% share with CAGR of 7.1%, sustained by specialized study centers and clinical trial sites focused on stent graft innovations.

Regional Outlook for the Stent Grafts Market

The global stent grafts market exhibits diverse growth patterns across key regions, driven by varying healthcare infrastructures, prevalence of vascular diseases, and technological adoption rates. North America leads with approximately 38% market share, performing over 350,000 endovascular aneurysm repairs annually, supported by advanced medical facilities and extensive R&D activities. Europe follows closely with a 31% share and nearly 270,000 procedures each year, benefiting from well-established healthcare systems and significant investments in vascular care.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America leads the stent grafts market with an estimated 38% global share, performing over 350,000 procedures annually. The USA dominates with more than 300,000 aneurysm repairs each year, 85% of which utilize endovascular stent grafts. Canada contributes approximately 40,000 procedures, driven by expanding vascular surgery programs. The region boasts over 1,200 hospitals equipped with advanced hybrid operating rooms, facilitating complex stent graft deployments, including fenestrated and branched grafts. The aging population in the USA, projected to exceed 70 million by 2030, intensifies demand for minimally invasive vascular treatments.

North America commands approximately 38% share of the global stent grafts market as of 2024–2025, reflecting the largest regional market, with more than 25,000 endovascular aneurysm repair (EVAR) procedures performed in the United States annually, driven by advanced healthcare infrastructure and high procedural volume, and exhibiting a CAGR of around 7.4%.

North America - Major Dominant Countries in the “Stent Grafts Market”

• United States: Market size leads regionally, capturing roughly 75–80% of the North American volume, with more than 25,000 EVARs per year, and a CAGR of about 7.3%, fueled by widespread adoption of minimally invasive techniques.
• Canada: Contributes near 10–12% of North America’s stent graft procedures, with several hundred hospital centers performing complex aortic repairs, and a CAGR of approximately 7.5%, supported by national health programs.
• Mexico: Accounts for about 5–7% share regionally, with ASCs and hospitals increasing stent graft procedures annually, and a CAGR near 7.6%, driven by rising cardiovascular disease incidence and healthcare investment.
• Puerto Rico: With around 2–3% share, performs a few hundred procedures annually, backed by regional medical centers and medical-tourism linkages, with a CAGR approximately 7.2%.
• Cuba: Makes up under 1% share, with dozens of aneurysm repair procedures annually, growing stent graft adoption slowly, with a CAGR of around 7.0%.

EUROPE

Europe holds a substantial 31% share of the global stent grafts market, with approximately 270,000 aneurysm repairs conducted annually. Germany leads with 90,000 procedures, followed by the UK and France with 70,000 and 50,000 respectively. The region benefits from widespread healthcare coverage and advanced surgical infrastructure, with more than 900 specialized vascular surgery centers. Adoption rates of endovascular aneurysm repair are high, reaching 78% across major countries. The European population aged 65 and above comprises over 20% of the total population, driving demand for vascular interventions.

Europe holds around 30–31% of the global stent grafts market, with annual EVAR procedure volumes exceeding 15,000 to 20,000 across nations such as Germany, the UK, and France, underpinned by universal healthcare systems and a high prevalence of aortic aneurysms, and showing a CAGR of approximately 7.2%.

Europe – Major Dominant Countries

• Germany: Germany is a key leader in the European stent grafts market, with an anticipated market size of approximately USD 480 million in 2025, representing around 27.5% of the regional share, and expanding steadily at a CAGR of 7.1% through 2034.
• United Kingdom: The United Kingdom holds a significant portion of the European market, expected to reach USD 320 million by 2025, accounting for about 18.3% of the regional stent grafts market, growing at a CAGR of 7.3% over the forecast period.
• France: France’s stent graft sector is forecast to be valued at roughly USD 250 million in 2025, capturing close to 14.3% of Europe’s market, with a stable growth rate of CAGR 7.0% through the projection timeline.
• Italy: Italy is predicted to generate market revenues near USD 200 million in 2025, accounting for approximately 11.5% of the European stent grafts market, growing steadily at a CAGR of 7.2% during the coming years.
• Spain: Spain is set to reach a market size of around USD 170 million by 2025, representing close to 9.7% of the regional share, with an expected growth rate of CAGR 7.4% through 2034.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 20% of the global stent grafts market, with over 180,000 procedures performed annually. China is the largest contributor, with 90,000 procedures, followed by Japan with 45,000 and India with 30,000. The market is expanding rapidly due to rising cardiovascular disease prevalence and increasing healthcare expenditure, estimated to grow over 12% annually in key countries. Government initiatives in China and India promote early diagnosis and treatment of aortic aneurysms, with screening programs covering over 8 million people annually.

The Asia-Pacific stent grafts market is estimated to reach around USD 1,050 million in 2025, holding close to 18.9% of the worldwide market share, driven by improving healthcare access, rising incidence of vascular diseases, and expanding healthcare infrastructure. The market in this region is growing at a comparatively higher CAGR of 8.0%, with China, Japan, and India leading in market penetration due to rising patient volumes and increased adoption of advanced vascular devices.

Asia – Major Dominant Countries

• China: China leads the Asian stent grafts market with a projected market size of approximately USD 360 million in 2025, representing about 34.3% of the total regional share, and is expected to grow at a robust CAGR of 8.2% during the forecast period.
• Japan: Japan holds a significant position in the Asia stent grafts sector, estimated at around USD 260 million by 2025, accounting for roughly 24.8% of the regional market, with a steady growth rate projected at a CAGR of 7.9% through 2034.
• India: India’s market for stent grafts is anticipated to reach USD 140 million in 2025, capturing nearly 13.3% of the Asia market share, with an expected accelerated growth pace marked by a CAGR of 8.5% over the coming years.
• South Korea: South Korea is forecast to generate about USD 90 million in stent graft revenue by 2025, holding approximately 8.6% of the regional share, and maintaining a healthy growth rate at a CAGR of 8.1% during the forecast timeline.
• Australia: Australia is estimated to contribute around USD 70 million to the Asian stent grafts market in 2025, accounting for close to 6.7% of the region’s market, with steady growth expected at a CAGR of 7.8% over the next decade.

MIDDLE EAST & AFRICA

The Middle East & Africa region holds approximately 3.8% of the global stent grafts market, performing around 35,000 aneurysm repair procedures annually. Saudi Arabia and UAE lead with 15,000 and 8,000 procedures respectively. Expanding healthcare infrastructure, with investments exceeding USD 3 billion over recent years, supports market growth. Increasing prevalence of vascular diseases in the region, with an estimated 0.5 million patients affected by aortic aneurysms, drives demand for stent grafts. The availability of modern surgical facilities in urban centers facilitates adoption of advanced devices.

The Middle East and Africa (MEA) stent grafts market is anticipated to be valued at approximately USD 315 million by 2025, contributing about 5.7% to the global market share. This growth is propelled by increasing healthcare investments, expanding private healthcare sectors, and rising cardiovascular disease prevalence. The region is expected to grow steadily at a CAGR of 7.8%, with the United Arab Emirates, Saudi Arabia, and South Africa emerging as key contributors to market expansion due to improved healthcare infrastructure and rising awareness about endovascular treatments.

Middle East & Africa – Major Dominant Countries

• United Arab Emirates: The United Arab Emirates is the leading country in the Middle East & Africa stent grafts market, with a projected market size of approximately USD 90 million in 2025, accounting for about 28.6% of the regional market share, and expected to grow at a CAGR of 7.9% through the forecast period.
• Saudi Arabia: Saudi Arabia holds a significant share in the regional stent grafts market, valued at around USD 70 million in 2025, representing nearly 22.2% of the Middle East & Africa market, with a growth rate projected at a CAGR of 8.1% over the next several years.
• South Africa: South Africa is estimated to generate approximately USD 50 million in 2025 from the stent grafts segment, contributing about 15.9% of the regional market share, with an expected CAGR of 7.7% during the forecast period.
• Israel: Israel’s stent grafts market is expected to reach close to USD 40 million in 2025, representing roughly 12.7% of the Middle East & Africa market, showing a promising growth trajectory with a CAGR of 7.8% through 2034.
• Egypt: Egypt is projected to account for approximately USD 30 million in 2025, making up around 9.5% of the regional stent grafts market, with a forecasted growth rate at a CAGR of 8.0% during the analysis period.

List of Top Stent Grafts Companies

• Medtronic Plc
• Endologix, Inc.
• Lifetech Scientific
• Braun Melsungen AG
• Abbott Laboratories
• Cook Medical Inc.
• Johnson & Johnson Services
• WL Gore & Associates
• R. Bard, Inc.
• Terumo Medical Corp

Medtronic Plc: Leading the market with a 30% share, Medtronic is known for its wide range of abdominal and thoracic stent graft products, with over 400,000 devices implanted worldwide.

Endologix, Inc.: Holding approximately 18% of the global market share, Endologix specializes in innovative abdominal aortic aneurysm stent grafts and fenestrated graft technologies, performing over 120,000 procedures annually.

Investment Analysis and Opportunities

The stent grafts market presents significant investment opportunities, driven by the growing prevalence of vascular diseases and rising adoption of minimally invasive procedures. In 2024 alone, global investments in stent graft R&D surpassed USD 500 million, focusing on improving device design and patient outcomes. Emerging markets in Asia-Pacific and Latin America are witnessing infrastructure development with over 1,000 new cardiovascular centers planned by 2026.

New Product Development

Recent product development focuses on enhancing graft flexibility, reducing complications, and improving anatomical fit. Over 35 new stent graft models were launched globally between 2023 and 2025, with 40% featuring fenestrated or branched designs to address complex aneurysms. Advanced materials such as nitinol alloys are utilized in 70% of new devices to increase durability and biocompatibility.

Five Recent Developments

• Launch of a modular fenestrated stent graft system enabling treatment of juxtarenal aneurysms in over 10,000 patients globally since 2023.
• Introduction of a drug-eluting stent graft designed to reduce neointimal hyperplasia, with clinical trials involving 1,200 patients completed in 2024.
• Approval of the first fully resorbable stent graft material by regulatory bodies in 2025, following successful implantation in 50 patients during pilot studies.
• Expansion of minimally invasive stent graft procedures in Asia-Pacific with over 25,000 surgeries performed using newly approved devices in 2024.
• Strategic acquisition of a fenestrated graft developer by a leading stent graft manufacturer, increasing their product portfolio by 15% in 2025.

Report Coverage of Stent Grafts Market

The Stent Grafts Market Report provides an in-depth analysis of global market trends, segmentation, regional performance, and competitive landscape. The report covers over 500,000 endovascular aneurysm repair procedures globally, analyzing types including abdominal, thoracic, and fenestrated grafts. It includes detailed insights on applications across hospitals, ambulatory surgical centers, and other healthcare facilities, with geographic segmentation spanning North America, Europe, Asia-Pacific, and Middle East & Africa.

Stent Grafts Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5980.59 Million in 2026
Market Size Value By	USD 11546.13 Million by 2035
Growth Rate	CAGR of 7.58% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Abdominal Aortic Stent Grafts Thoracic Aortic Stent Grafts Fenestrated Aortic Stent Grafts By Application : Hospitals Ambulatory Surgical Centers Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample